HDAC8 is activated by SREBP1, an insulin-responsive transcription factor, which activates the transcription of lipogenic genes, and HDAC8 deficiency in obesity-associated mouse models of NASH and HCC ameliorated insulin resistance, reducing triglyceride levels and tumour growth. Here, HDAC8 is linked to neoplasm.